Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data

Current Medical Research and Opinion

Lower Medical Cost Associated with Aripiprazole Once-Monthly Compared to Oral Atypical Antipsychotics in Patients with Schizophrenia

AMCP Managed Care and Specialty Pharmacy Annual Meeting